axitinib,sunitinib,pazopanib,cabozantinib,nivolumab,ipilimumab
novartis,bms,pfizer
['gu ', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'axitinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'biomarker', 'nivo', 'bionikk', 'marker ']
bionikk 1y on-continue to show promise meanwhile in clinic-we continue to rely imdc+the best guess-io/io, io/tki,triple, tki mono risks vs rr vs os vs qol vs tft(treatment free time) lots for pts &amp; us to digest.the quest for a readily applicable biomarker goes on in mrcc #gu23 
Honorary Geordie, a mum and clinical oncologist (#Radonc+med onc😉). Made in the Northeast, UK. "90% of life is showing up." views are mine - share you may!